← Evidence map

ArticleTranslational oncology2021

Anti-tumor effects of rigosertib in high-risk neuroblastoma.

Katarzyna Radke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

8 papers cite it

2021
2022
2023
2024
2025
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34118691